Literature DB >> 19017737

Cardiovascular injury and repair in chronic obstructive pulmonary disease.

William Macnee1, John Maclay, David McAllister.   

Abstract

Cardiovascular disease represents a considerable burden in terms of both morbidity and mortality in patients with chronic obstructive pulmonary disease (COPD). For 20 years, forced expiratory volume in 1 second (FEV(1)) has been an established predictor of cardiovascular mortality among smokers, never-smokers, and patients with COPD. We review evidence for increased cardiovascular risk in COPD. In addition, we assess the emerging evidence which suggests that hypoxia, systemic inflammation, and oxidative stress in patients with COPD may cause cardiovascular disease. We also discuss alternative hypotheses that the endothelium and connective tissues in the arteries and lungs of patients with COPD and cardiovascular disease have a shared susceptibility to these factors.

Entities:  

Mesh:

Year:  2008        PMID: 19017737      PMCID: PMC2643206          DOI: 10.1513/pats.200807-071TH

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  137 in total

1.  Death certificate reporting of confirmed airways obstructive disease.

Authors:  A E Camilli; D R Robbins; M D Lebowitz
Journal:  Am J Epidemiol       Date:  1991-04-15       Impact factor: 4.897

2.  Aging, the aging lung, and senile emphysema are different.

Authors:  Shinji Teramoto; Masaki Ishii
Journal:  Am J Respir Crit Care Med       Date:  2007-01-15       Impact factor: 21.405

Review 3.  Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury.

Authors:  Christopher A Papaharalambus; Kathy K Griendling
Journal:  Trends Cardiovasc Med       Date:  2007-02       Impact factor: 6.677

4.  Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study.

Authors:  Scott W Brouilette; Jasbir S Moore; Alex D McMahon; John R Thompson; Ian Ford; James Shepherd; Chris J Packard; Nilesh J Samani
Journal:  Lancet       Date:  2007-01-13       Impact factor: 79.321

5.  Statin use is associated with reduced mortality in COPD.

Authors:  V Søyseth; P H Brekke; P Smith; T Omland
Journal:  Eur Respir J       Date:  2006-10-18       Impact factor: 16.671

6.  C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease.

Authors:  Morten Dahl; Jørgen Vestbo; Peter Lange; Stig E Bojesen; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Journal:  Am J Respir Crit Care Med       Date:  2006-10-19       Impact factor: 21.405

7.  Association between markers of emphysema and more severe chronic obstructive pulmonary disease.

Authors:  P Boschetto; S Quintavalle; E Zeni; S Leprotti; A Potena; L Ballerin; A Papi; G Palladini; M Luisetti; L Annovazzi; P Iadarola; E De Rosa; L M Fabbri; C E Mapp
Journal:  Thorax       Date:  2006-06-12       Impact factor: 9.139

8.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Authors:  Peter M A Calverley; Julie A Anderson; Bartolome Celli; Gary T Ferguson; Christine Jenkins; Paul W Jones; Julie C Yates; Jørgen Vestbo
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

9.  Lung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities study.

Authors:  Atsushi Hozawa; Joanne L Billings; Eyal Shahar; Tetsuya Ohira; Wayne D Rosamond; Aaron R Folsom
Journal:  Chest       Date:  2006-12       Impact factor: 9.410

10.  Cigarette smoke induces cellular senescence.

Authors:  Toru Nyunoya; Martha M Monick; Aloysius Klingelhutz; Timur O Yarovinsky; Jeffrey R Cagley; Gary W Hunninghake
Journal:  Am J Respir Cell Mol Biol       Date:  2006-07-13       Impact factor: 6.914

View more
  32 in total

Review 1.  Chronic obstructive pulmonary disease and obstructive sleep apnoea-the overlap syndrome.

Authors:  Walter T McNicholas
Journal:  J Thorac Dis       Date:  2016-02       Impact factor: 2.895

2.  [COPD and heart disease].

Authors:  H Watz; M Arzt
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

Review 3.  The epidemiology of vascular dysfunction relating to chronic obstructive pulmonary disease and emphysema.

Authors:  R Graham Barr
Journal:  Proc Am Thorac Soc       Date:  2011-11

4.  Human endothelial progenitor cells isolated from COPD patients are dysfunctional.

Authors:  Xiaoran Liu; Canmao Xie
Journal:  Mol Cell Biochem       Date:  2011-12-04       Impact factor: 3.396

Review 5.  The cardiorenal syndrome in heart failure: cardiac? renal? syndrome?

Authors:  Filippos Triposkiadis; Randall C Starling; Harisios Boudoulas; Gregory Giamouzis; Javed Butler
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

6.  Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance.

Authors:  Stephen J Ives; Ryan A Harris; Melissa A H Witman; Anette S Fjeldstad; Ryan S Garten; John McDaniel; D Walter Wray; Russell S Richardson
Journal:  Hypertension       Date:  2013-12-09       Impact factor: 10.190

7.  Increased sympathetic nerve activity in COPD is associated with morbidity and mortality.

Authors:  Stefan Andreas; Helge Haarmann; Stephan Klarner; Gerd Hasenfuss; Tobias Raupach
Journal:  Lung       Date:  2013-12-22       Impact factor: 2.584

8.  Whole-genome analyses of lung function, height and smoking.

Authors:  Luc Janss; Torben Sigsgaard; Daniel Sorensen
Journal:  Ann Hum Genet       Date:  2014-08-01       Impact factor: 1.670

9.  Diastolic dysfunction and heart failure with a preserved ejection fraction: Relevance in critical illness and anaesthesia.

Authors:  R Maharaj
Journal:  J Saudi Heart Assoc       Date:  2012-02-01

10.  Airflow Limitation and Endothelial Dysfunction. Unrelated and Independent Predictors of Atherosclerosis.

Authors:  Divay Chandra; Aman Gupta; Patrick J Strollo; Carl R Fuhrman; Joseph K Leader; Jessica Bon; William A Slivka; Ali Hakim Shoushtari; Jennifer Avolio; Kevin E Kip; Steven Reis; Frank C Sciurba
Journal:  Am J Respir Crit Care Med       Date:  2016-07-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.